(Q92684130)

English

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

scientific article published on 25 March 2019

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

phase II clinical trial

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

Carol Aghajanian

15

object named as

Carol Aghajanian

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1

object named as

Vicky Makker

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

author name string

Drew Rasco

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Nicholas J Vogelzang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Marcia S Brose

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Allen L Cohn

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

James Mier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Christopher Di Simone

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

David M Hyman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Daniel E Stepan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Corina E Dutcus

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Emmett V Schmidt

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Matthew Guo

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Pallavi Sachdev

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Robert Shumaker

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Matthew Taylor

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

publication date

25 March 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

711-718

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

The Immune Biology of Microsatellite-Unstable Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of adverse effects of anti-VEGF therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pembrolizumab versus Ipilimumab in Advanced Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2819%2930020-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(19)30020-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30922731%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q92684130&oldid=2046354088"